Research programme:Wnt signalling pathway inhibitors - Kyowa Kirin
Alternative Names: K-756Latest Information Update: 16 Jul 2019
Price :
$50 *
At a glance
- Originator Kyowa Hakko Kirin
- Developer Kyowa Kirin
- Class Small molecules
- Mechanism of Action Tankyrase inhibitors; Wnt signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Cancer in Japan (PO)
- 22 Oct 2013 Pharmacodynamics data from early research in Cancer presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2013)
- 21 Oct 2013 Early research in Cancer in Japan (PO)